Association between Grade 4 Neutropenia and Abnormal Liver Function Test Values after Initial Administration of Docetaxel for Prostate Cancer Patients
-
Published:2020-11-10
Issue:11
Volume:46
Page:647-654
-
ISSN:1346-342X
-
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
-
language:en
-
Short-container-title:Jpn. J. Pharm. Health Care Sci.
Author:
Kageyama Akira1, Nakazawa Yusuke1, Harada Dai1, Kitamura Masaki1, Kawakubo Takashi1, Asano Koji2
Affiliation:
1. Department of Pharmacy, The Jikei University Hospital 2. Department of Urology, The Jikei University Hospital
Publisher
Japanese Society of Pharmaceutical Health Care and Sciences
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference13 articles.
1. 1)Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA, TAX 327 Investigators, Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer, N Engl J Med, 2004, 351, 1502-1512. 2. 2)Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED, Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer, N Engl J Med, 2004, 351, 1513-1520. 3. 3)日本泌尿器科学会編, “前立腺癌診療ガイドライン”, 2016年版, メディカルレビュー社, 東京, 2016, p223. 4. 5)工藤翔二, 日野光紀, 藤田昭久, 五十嵐敢, 有田健一, 仁井谷久暢, 田口鐵男, 非小細胞肺癌に対するRP56976(Docetaxel)の後期第Ⅱ相臨床試験, 癌と化学療法, 1994, 21, 2617-2623. 5. 8)Mori T, Hosokawa K, Kinoshita Y, Watanabe A, Yamaguchi T, Kuroboshi H, Kato Y, Yasuda J, Fujita H, Nakata Y, Honjo H, A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer, Int J Clin Oncol, 2007, 12, 205-211.
|
|